Related Experiment Video
Updated: Jul 30, 2026

05:05
Ultrasound Cyclo Plasty in Eyes with Glaucoma
Published on: January 26, 2018
[Therapeutic effect of phacoemulsification for closed-angle glaucoma]
Min Zhu1, Gang-ping Zhao, Lin-li Yu
1Department of Ophthalmology, First People's Hospital of Foshan, Foshan 528000, China. zmin@fsyyy.com.cn
Summary
Phacoemulsification with intraocular lens implantation effectively treats primary closed-angle glaucoma complicated by cataracts. The procedure improves vision and lowers eye pressure, offering a valuable therapeutic option.
Area of Science:
- Ophthalmology
- Glaucoma Research
- Cataract Surgery
Context:
- Primary closed-angle glaucoma (PCG) often coexists with cataracts, complicating treatment.
- Managing elevated intraocular pressure (IOP) is crucial in PCG to prevent optic nerve damage.
- Cataract surgery can impact anterior chamber dynamics and IOP in glaucoma patients.
Purpose:
- To evaluate the efficacy of phacoemulsification with intraocular lens (IOL) implantation in eyes with PCG and cataracts.
- To assess the impact of the procedure on visual acuity, IOP, anterior chamber depth, and angle status.
- To determine the long-term (6-month) outcomes of this combined surgical approach.
Summary:
- Phacoemulsification and foldable IOL implantation were performed on 55 patients (58 eyes) with PCG and cataracts.
- Postoperative assessments included visual acuity, IOP, anterior chamber depth, and anterior chamber angle.
- Follow-up was conducted for six months to evaluate sustained effects.
Impact:
- The study demonstrated significant improvements in best-corrected visual acuity and anterior chamber depth post-surgery.
- Phacoemulsification effectively reduced intraocular pressure in patients with PCG and cataracts.
- The procedure led to partial reopening of previously closed anterior chamber angles, indicating a positive structural change.
Related Concept Videos
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...

